Call it a case of tempting fate or instant karma-the cosmos sought its inevitable revenge when Martin Shkreli, the hip-hop-loving, drug-price-inflating biotech executive, was arrested, indicted, and perp-walked on Dec. 17. But the activities that got him crosswise with the feds aren't what the 32-year-old Twitter addict with the sardonic smirk will be remembered for. What's so troubling and important about his story is that the way he ran his drug companies-the amoral but probably legal business plans he employed-were of a piece with mainstream pharmaceutical marketing.
展开▼
